BRPI0503173A - composição para reduzir lipìdios sangüìneos - Google Patents
composição para reduzir lipìdios sangüìneosInfo
- Publication number
- BRPI0503173A BRPI0503173A BRPI0503173-7A BRPI0503173A BRPI0503173A BR PI0503173 A BRPI0503173 A BR PI0503173A BR PI0503173 A BRPI0503173 A BR PI0503173A BR PI0503173 A BRPI0503173 A BR PI0503173A
- Authority
- BR
- Brazil
- Prior art keywords
- chromium
- composition
- blood lipids
- iii
- reduce blood
- Prior art date
Links
- 239000008280 blood Substances 0.000 title abstract 4
- 210000004369 blood Anatomy 0.000 title abstract 4
- 150000002632 lipids Chemical class 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 3
- 229910052804 chromium Inorganic materials 0.000 abstract 3
- 239000011651 chromium Substances 0.000 abstract 3
- 150000001845 chromium compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 abstract 1
- 102000010445 Lactoferrin Human genes 0.000 abstract 1
- 108010063045 Lactoferrin Proteins 0.000 abstract 1
- 229940046374 chromium picolinate Drugs 0.000 abstract 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 abstract 1
- LJAOOBNHPFKCDR-UHFFFAOYSA-K chromium(3+) trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cr+3] LJAOOBNHPFKCDR-UHFFFAOYSA-K 0.000 abstract 1
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 abstract 1
- 235000007831 chromium(III) chloride Nutrition 0.000 abstract 1
- 239000011636 chromium(III) chloride Substances 0.000 abstract 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 abstract 1
- 229910000356 chromium(III) sulfate Inorganic materials 0.000 abstract 1
- 235000015217 chromium(III) sulphate Nutrition 0.000 abstract 1
- 239000011696 chromium(III) sulphate Substances 0.000 abstract 1
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 abstract 1
- HPCCGRCEBFBZQP-UHFFFAOYSA-N chromium;pyridine-3-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CN=C1 HPCCGRCEBFBZQP-UHFFFAOYSA-N 0.000 abstract 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 abstract 1
- 229940078795 lactoferrin Drugs 0.000 abstract 1
- 235000021242 lactoferrin Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
Abstract
"COMPOSIçãO PARA REDUZIR LIPìDIOS SANGüìNEOS". Apresenta-se uma composição para reduzir os lipídios sangüíneos. A composição inclui lactoferrina e um composto de cromo trivalente. O composto de cromo trivalente da presente invenção é selecionado no grupo que consiste em cloreto de cromo (III) hexaidratado, cloreto de cromo (III), acetato de cromo (III), sulfato de cromo (III), picolinato de cromo, nicotinato de cromo, sais inorgânicos de cromo trivalente, sais orgânicos de cromo trivalente e suas combinações. A presente invenção também apresenta um processo para reduzir os lipídios sangüíneos de um receptor.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW093123462A TW200605902A (en) | 2004-08-05 | 2004-08-05 | Composition for lowering blood lipid |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0503173A true BRPI0503173A (pt) | 2006-05-16 |
Family
ID=34984068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0503173-7A BRPI0503173A (pt) | 2004-08-05 | 2005-08-02 | composição para reduzir lipìdios sangüìneos |
Country Status (13)
Country | Link |
---|---|
US (2) | US20060030519A1 (pt) |
JP (1) | JP2006045233A (pt) |
KR (1) | KR100699658B1 (pt) |
AU (1) | AU2005202962B2 (pt) |
BR (1) | BRPI0503173A (pt) |
CH (1) | CH697675B1 (pt) |
DE (1) | DE102005032094A1 (pt) |
FR (1) | FR2873926B1 (pt) |
GB (1) | GB2416693B (pt) |
IT (1) | ITMI20051446A1 (pt) |
MY (1) | MY161821A (pt) |
NL (1) | NL1029585C2 (pt) |
TW (1) | TW200605902A (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI276442B (en) | 2005-07-05 | 2007-03-21 | Maxluck Biotechnology Corp | Composition of controlling and preventing heart disease |
JP5045879B2 (ja) * | 2006-06-07 | 2012-10-10 | 株式会社龍泉堂 | インスリン抵抗性の改善効果、体重増加の抑制効果、及び脂肪肝の予防及び改善効果を有する混合物 |
TW201002332A (en) | 2008-07-07 | 2010-01-16 | Univ Nat Chunghsing | Composition for preventing and controlling fatty liver disease |
TWI454221B (en) * | 2008-07-14 | 2014-10-01 | Composition and method for inhibiting formation of body fat | |
CN101632832B (zh) * | 2008-07-22 | 2013-02-06 | 加特福生物科技股份有限公司 | 用以减少体脂肪形成的组成物及其用途 |
CN103960368A (zh) * | 2014-05-19 | 2014-08-06 | 冯紫玲 | 一种孕妇营养奶粉及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948772A (en) * | 1998-08-28 | 1999-09-07 | Ambi Inc. | Chromium picolinate compositions and uses thereof |
TW471951B (en) * | 2000-04-11 | 2002-01-11 | Ling-Huei Cheng | Thivalent chromium milk product and method for producing the same |
CN1185258C (zh) * | 2000-05-19 | 2005-01-19 | 程伶辉 | 三价铬复合物及其应用 |
CN1114618C (zh) * | 2000-05-19 | 2003-07-16 | 程伶辉 | 三价铬复合物、其乳制品及其制造方法 |
JP3633852B2 (ja) * | 2000-06-06 | 2005-03-30 | 伶輝 程 | 三価クロム複合物、その乳製品およびその製造方法 |
US20030040475A1 (en) * | 2001-01-16 | 2003-02-27 | Yasuhiro Toba | Agents for improving lipid metabolism and reducing high blood pressure |
CA2471766C (en) * | 2001-12-28 | 2011-01-11 | Nrl Pharma, Inc. | Compositions for improving lipid metabolism |
AU2003291206A1 (en) * | 2002-12-04 | 2004-06-23 | Agennix Incorporated | Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease |
-
2004
- 2004-08-05 TW TW093123462A patent/TW200605902A/zh not_active IP Right Cessation
-
2005
- 2005-05-26 US US11/137,498 patent/US20060030519A1/en not_active Abandoned
- 2005-07-06 AU AU2005202962A patent/AU2005202962B2/en not_active Ceased
- 2005-07-06 MY MYPI20053081A patent/MY161821A/en unknown
- 2005-07-08 DE DE102005032094A patent/DE102005032094A1/de not_active Withdrawn
- 2005-07-13 FR FR0507502A patent/FR2873926B1/fr not_active Expired - Fee Related
- 2005-07-21 NL NL1029585A patent/NL1029585C2/nl not_active IP Right Cessation
- 2005-07-26 IT IT001446A patent/ITMI20051446A1/it unknown
- 2005-07-29 KR KR1020050069581A patent/KR100699658B1/ko active IP Right Grant
- 2005-08-02 BR BRPI0503173-7A patent/BRPI0503173A/pt not_active Application Discontinuation
- 2005-08-03 CH CH01291/05A patent/CH697675B1/it not_active IP Right Cessation
- 2005-08-04 JP JP2005226680A patent/JP2006045233A/ja active Pending
- 2005-08-04 GB GB0516025A patent/GB2416693B/en not_active Expired - Fee Related
-
2007
- 2007-03-30 US US11/730,231 patent/US20070178172A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060030519A1 (en) | 2006-02-09 |
DE102005032094A1 (de) | 2006-03-16 |
AU2005202962B2 (en) | 2008-02-21 |
AU2005202962A1 (en) | 2006-02-23 |
ITMI20051446A1 (it) | 2006-02-06 |
TW200605902A (en) | 2006-02-16 |
CH697675B1 (it) | 2009-01-15 |
KR100699658B1 (ko) | 2007-03-23 |
TWI348913B (pt) | 2011-09-21 |
FR2873926B1 (fr) | 2009-10-30 |
JP2006045233A (ja) | 2006-02-16 |
GB0516025D0 (en) | 2005-09-14 |
KR20060048947A (ko) | 2006-05-18 |
MY161821A (en) | 2017-05-15 |
GB2416693A (en) | 2006-02-08 |
FR2873926A1 (fr) | 2006-02-10 |
GB2416693B (en) | 2010-01-20 |
US20070178172A1 (en) | 2007-08-02 |
NL1029585C2 (nl) | 2007-02-09 |
NL1029585A1 (nl) | 2006-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0503173A (pt) | composição para reduzir lipìdios sangüìneos | |
RS52780B (en) | MEANS OF PREVENTION AND TREATMENT OF DISORDERS CONCERNING MODULATION OF RYR RECEPTORS | |
BRPI0518798A2 (pt) | composto, composiÇço farmacÊutica, e, mÉtodos para tratar diabete tipo ii e para tratar uma condiÇço ou distérbio | |
BRPI0409164A (pt) | pirazóis substituìdos | |
ATE504569T1 (de) | Neue salze von bazedoxifen | |
BRPI0410037A (pt) | inibidores da fosfatidilinositol 3-cinase | |
BR112012022634A2 (pt) | síntese de derivados de alto-tocoferolquinona e métodos de utilização dos mesmos | |
ATE523486T1 (de) | Pleuromutilinderivate zur behandlung von durch mikroben vermittelten krankheiten | |
ECSP099330A (es) | Compuesto de indol | |
RS53599B1 (en) | PIRIDON DERIVATIVES FOR STRESS MODULATION OF ACTIVATED PROTEIN KINASE SYSTEMS | |
BRPI0518807B8 (pt) | substrato que contém um revestimento de controle de odor | |
BRPI0507499A (pt) | composto ou um sal farmaceuticamente aceitável ou hidrato dos mesmos, composição farmacêutica, uso do composto, e, métodos para tratar distúrbios mediados por mglur 5 e para inibir a ativação de receptores de mglur 5 | |
BR112013011172A2 (pt) | compostos antidiabéticos | |
NI201000225A (es) | Composición y proceso - 356. | |
BR112013031131A2 (pt) | complexos de rutênio, método para a preparação e aplicação dos mesmos em reações metátese de olefina | |
BRPI0406596A (pt) | Métodos para tratar a dor articular e melhorar o sono utilizando um agonista/antagonista de estrogênio | |
BRPI0411738A (pt) | compostos orgánicos | |
BR0215258A (pt) | Moduladores de receptor x de fìgado de tioéter aromático | |
BRPI0512558A (pt) | compostos quìmicos | |
BRPI0513272A (pt) | compostos orgánicos | |
BRPI0719869A2 (pt) | Composto ou um sal do mesmo, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono em uma mamífero, e, uso do composto. | |
BRPI0601290A (pt) | composição para prevenção e tratamento de distúrbios cardiovasculares | |
MX2009007319A (es) | Composicion para prevenir y tratar el higado graso. | |
BRPI0509986A (pt) | composto, composição farmacêutica, e, agente mono terapêutico ou agente terapêutico em combinação | |
BR0210009A (pt) | Agentes co-retardadores para preparação de salmoura purificada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |